The use of aescin lysinate in the treatment of some neurological diseases


DOI: https://dx.doi.org/10.18565/pharmateca.2019.13.85-90

N.V. Pizova, A.V. Pizov

Yaroslavl State Medical University, Yaroslavl, Russia
The article presents information about the aescin lysinate, registered as a medicine in Russia in 2011. Aescin lysinate aescinate is used for acute and chronic cerebrovascular disorders, traumatic brain injuries. The drug has a pronounced and rapid decongestant, as well as neuroprotective action. The efficacy and safety of the use of the aescin lysinate aescinate for patients with traumatic brain injuries and acute and chronic cerebrovascular disorders have been shown in a number of studies.
Keywords: aescin lysinate, cerebrovascular diseases, brain injury

About the Autors


Corresponding author: Natalya V. Pizova, MD, Professor, Department of Neurology and Medical Genetics with the Course of Neurosurgery, Yaroslavl State Medical University, Yaroslavl, Russia; e-mail: pizova@yandex.ru
Address: 6, Chkalova Street, Yaroslavl 150054, Russian Federation


Бионика Медиа